2010
DOI: 10.1016/j.ejphar.2010.03.050
|View full text |Cite
|
Sign up to set email alerts
|

Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
55
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(60 citation statements)
references
References 24 publications
5
55
0
Order By: Relevance
“…1, A and B), consistent with the previous reports by our group and others using immunohistochemistry (Afeli et al, 2013;Anderson et al, 2013). K V 7 channel activators and inhibitors such as retigabine and XE991 have provided a useful pharmacological approach for elucidating K V 7 channel roles in urinary bladder function Sheldon et al, 2002;Streng et al, 2004;Rode et al, 2010;Svalø et al, 2012Svalø et al, , 2013Svalø et al, , 2015Petkov, 2012;Afeli et al, 2013;Anderson et al, 2013). However, retigabine and XE991 do not effectively distinguish among K V 7.2-K V 7.5 and K V 7.1-K V 7.5 channel subtypes, respectively.…”
Section: Discussionsupporting
confidence: 79%
“…1, A and B), consistent with the previous reports by our group and others using immunohistochemistry (Afeli et al, 2013;Anderson et al, 2013). K V 7 channel activators and inhibitors such as retigabine and XE991 have provided a useful pharmacological approach for elucidating K V 7 channel roles in urinary bladder function Sheldon et al, 2002;Streng et al, 2004;Rode et al, 2010;Svalø et al, 2012Svalø et al, , 2013Svalø et al, , 2015Petkov, 2012;Afeli et al, 2013;Anderson et al, 2013). However, retigabine and XE991 do not effectively distinguish among K V 7.2-K V 7.5 and K V 7.1-K V 7.5 channel subtypes, respectively.…”
Section: Discussionsupporting
confidence: 79%
“…Kv7 channels have an important physiological role in vascular tissues, [11][12][13][14][15][16][17][18][19][20][21] as well as nonvascular tissues, [43][44][45] in addition to their established role in neurons, cardiomyocytes, and epithelia. In each vascular tissue studied previously, quantitative polymerase chain reaction and protein analysis revealed that KCNQ1, KCNQ4, and KCNQ5 were predominant, with a minimal contribution from KCNQ2 and KCNQ3.…”
Section: Discussionmentioning
confidence: 99%
“…RTG received FDA's black box warning mainly because of its link to retinal abnormalities and blue skin discoloration that might be permanent and irreversible (Brickel et al, 2012;Faulkner and Burke 2013). Additionally, RTG has been reported to cause bladder dysfunction, including dysuria and urinary hesitation, which may be related to the potentiation of KCNQ5 expressed in the bladder (Streng et al, 2004;Rode et al, 2010). Therefore, our rationale for developing RTG derivatives was to enhance its brain-toplasma ratio and improve its anticonvulsant potency.…”
Section: Introductionmentioning
confidence: 99%